Announcements

Coss-Phelps Lab: "Jabez Biosciences Presents First-in-Human Pharmacokinetic and Pharmacodynamic Data for JBZ-001 at AACR Annual Meeting 2026"

May 13, 2026 In the Media
Jabez Biosciences, Inc., a clinical-stage biopharmaceutical company developing novel therapies targeting cancer metabolism, today announced the presentation of first-in-human pharmacokinetic (PK) and pharmacodynamic (PD) data from the ongoing Phase 1 clinical trial of JBZ-001 (HOSU-53) at the American Association for Cancer Research (AACR) Annual Meeting 2026. The poster, titled "Clinical Pharmacokinetic and Pharmacodynamic of JBZ-001 (HOSU-53): Comparison of First-in-Human Data with Translational Preclinical Predictions," was presented by investigators from The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and the START Center for Cancer Research.

Upgrade now to the tap-enabled BuckID card

May 12, 2026 Announcements
As part of Ohio State’s ongoing modernization of BuckID access controls, the legacy magnetic stripe card readers on the Xeroxes in Parks and Riffe will be upgraded between May 18 and mid-June with more secure contactless “tap” readers.

Celebrating the Class of 2026 MS HSPAL graduates

May 11, 2026 Announcements
Graduates, family and friends, alumni, and faculty and staff gathered at the Jack Nicklaus Museum on May 11 for the MS Health-System Pharmacy Administration and Leadership (MS HSPAL) program graduation celebration.